Hers Weight Loss Reviews – Big Brand, Big Caveats

Hers (forhers.com) is the women-focused arm of Hims & Hers Health, a publicly traded telehealth company (NYSE: HIMS) that has aggressively expanded into GLP-1 weight loss. They advertise compounded semaglutide at "$199/month" and oral medication kits starting at $69/month. The brand recognition is strong, the BBB rating is A+, and the platform is polished. But look closer and you'll find the $199/month rate requires $1,194+ paid upfront, an FDA warning letter from September 2025 about their compounded semaglutide marketing, state restrictions that exclude Texas, New York, California, Florida, and Georgia from GLP-1 access, and persistent complaints about cancellation difficulties. Here's our complete analysis.

What Is Hers?

Hers is a women-focused telehealth platform originally launched for hair loss treatment that has since expanded into weight loss, skincare, mental health, and sexual wellness. It is part of Hims & Hers Health, Inc. (NYSE: HIMS), one of the largest publicly traded telehealth companies in the United States. This is not a scrappy startup — it's a well-funded, publicly traded corporation with significant marketing spend and brand awareness.

For weight loss specifically, Hers takes a dual-track approach. The first track is injectable compounded semaglutide, the same active ingredient found in brand-name Ozempic and Wegovy but produced by compounding pharmacies rather than Novo Nordisk. The second track is their Oral Medication Kits, which combine medications like metformin, bupropion, and naltrexone into customized blends. These oral kits are a genuinely different offering from what most GLP-1 telehealth providers sell.

The consultation model is 100% asynchronous in most states. You fill out an online questionnaire, a provider reviews your answers, and if approved, medications ship to your door. There are no video calls required in most cases. Hers also provides a companion app for tracking weight, water intake, and sleep — adding a lifestyle layer that many competitors lack.

What They Offer

• Compounded Semaglutide Injectable: $199/month on 6-month plan ($1,194 upfront), or $399/month paid monthly
• Oral Medication Kits: Metformin, bupropion, naltrexone blends starting at $69/month (10-month plan)
• Branded GLP-1 options listed: Ozempic, Wegovy, Mounjaro, Zepbound, generic liraglutide (insurance-dependent)
• Free anti-nausea medication (ondansetron) included if clinically eligible
• Hers companion app for tracking weight, water, and sleep
• 100% asynchronous consultations — no video calls in most states
• FSA/HSA eligible payments accepted
• Publicly traded company (NYSE: HIMS) with A+ BBB rating

The breadth of options is a legitimate strength. Patients who aren't candidates for injectable GLP-1s (or who live in restricted states) can still access the oral medication kits. The inclusion of free ondansetron for nausea management is a nice touch, since GLP-1 side effects like nausea are extremely common in early weeks.

Hers Pricing

Hers pricing is where things get complicated — and where many customers feel misled. The headline "$199/month" figure is technically accurate but deeply misleading, because it requires a 6-month upfront commitment of $1,194. If you want to pay month-to-month, the actual cost is $399/month — double the advertised rate.

For context, CoreAge Rx offers compounded semaglutide at $99/month with genuine month-to-month billing — no upfront bulk payment required. That's $100/month less than Hers' actual monthly rate, or a $1,200 annual savings. Even at the 6-month upfront rate, Hers is still $100/month more than CoreAge Rx. The oral medication kits at $69/month are more competitively priced, but they are a fundamentally different treatment approach than GLP-1 injectables.

It's also worth noting that compounded semaglutide — the medication Hers provides for their injectable program — is not FDA-approved. The FDA has specifically warned about the risks of compounded semaglutide products, and Hers itself received an FDA warning letter in September 2025 related to their marketing of these products.

My Experience With Hers

I tested the Hers weight loss program to evaluate the sign-up process, consultation quality, and overall experience. Here's what I found:

Sign-Up Process

The Hers website is slick and well-designed — clearly benefiting from their substantial marketing budget. The sign-up flow walks you through a health questionnaire covering medical history, current medications, BMI, and weight loss goals. The interface is clean and mobile-friendly, which you'd expect from a company of this size.

Here's where it gets tricky: the pricing presentation during checkout is where many customers report feeling blindsided. The "$199/month" number is front and center throughout the marketing, but the checkout flow reveals this requires a $1,194 upfront payment for 6 months. The true month-to-month option at $399/month is presented as the less attractive alternative. This is a legitimate customer experience complaint — not technically dishonest, but designed to anchor you on a price that requires a large upfront commitment.

Consultation Quality

The consultation is fully asynchronous in most states — you fill out the questionnaire and a provider reviews it without a live conversation. An independent review from ChoosingTherapy.com gave Hers just 3 out of 5 stars, recommending it primarily for prescription refills rather than new patients, specifically citing a lack of meaningful provider oversight.

This is a meaningful concern. GLP-1 medications have real side effects, dosing needs to be titrated carefully, and patients benefit from having an actual relationship with their prescribing provider. The asynchronous model optimizes for convenience at the expense of clinical depth. For patients who are already experienced with GLP-1s and just need refills, this might be fine. For first-time users, the lack of a real consultation is a drawback.

Medication Delivery & Quality

Positive Trustpilot reviews frequently mention convenience and some report significant weight loss — 30+ pounds in some cases. However, ConsumerAffairs reviews paint a different picture. Multiple customers report being charged without receiving their medication, receiving shipments with "dull needles" that made injection painful, and experiencing side effects severe enough to require emergency room visits without adequate warning from the platform.

The inconsistency in customer experience is notable. Some users love the service; others describe it as a nightmare. This polarization is common with large-scale telehealth companies that prioritize volume over personalized care.

Cancellation Experience

Cancellation is one of the biggest pain points reported across multiple review platforms. BBB complaints frequently cite difficulty canceling subscriptions, being charged after requesting cancellation, and a lack of clear communication about the cancellation process. For a company of this size and reputation, the volume of cancellation-related complaints is concerning and suggests a systemic issue rather than isolated incidents.

Pros and Cons

Is Hers Legit?

Yes, Hers is a legitimate company — but "legitimate" and "recommended" are not the same thing. Hims & Hers Health is a publicly traded company on the NYSE, subject to SEC reporting requirements, financial audits, and regulatory scrutiny that fly-by-night telehealth startups don't face. The A+ BBB rating and 3.79/5 star average across roughly 7,000 BBB reviews confirm that they are a real business that resolves most complaints.

However, the FDA warning letter from September 2025 is a significant concern. The FDA specifically took issue with how Hers marketed their compounded semaglutide products. This doesn't mean the medication itself is dangerous (compounded semaglutide is widely used across the telehealth industry), but it does mean the FDA found Hers' marketing claims problematic enough to issue a formal warning. For a company of this size, receiving an FDA warning letter is a serious regulatory event.

The state restrictions are another legitimacy consideration. Hers does not offer injectable GLP-1 programs in Texas, New York, California, Florida, or Georgia — five of the most populated states in the country. Instead, customers in those states are steered toward the oral medication kits. This likely reflects state-specific regulations around compounded medications or telehealth prescribing, but it means a huge portion of the U.S. population cannot access their flagship GLP-1 product.

• Publicly traded (NYSE: HIMS) with SEC oversight
• A+ BBB rating — 3.79/5 stars from ~7,000 reviews
• Trustpilot: ~6,092 reviews with mixed sentiment
• FDA warning letter (September 2025) about compounded semaglutide marketing
• GLP-1 unavailable in TX, NY, CA, FL, GA
• Persistent cancellation complaints suggest systemic issue

Who Is Hers Best For?

Hers is best suited for women who specifically want a women-branded platform and are comfortable with the upfront payment model. If you value having a well-known brand name behind your weight loss program, want a companion tracking app, and are willing to pay $1,194 upfront for 6 months of compounded semaglutide, Hers delivers a polished experience.

The oral medication kits are arguably Hers' strongest offering for many women. At $69/month, the combination of metformin, bupropion, and naltrexone provides a non-injectable approach that can support weight loss without the commitment and cost of GLP-1 injectables. For women who are needle-averse or who don't qualify for GLP-1 treatment, the oral kits fill a genuine gap in the market.

Hers is probably not the best fit if: You live in Texas, New York, California, Florida, or Georgia (no GLP-1 access). You want affordable month-to-month billing without large upfront payments. You want a live consultation with your prescribing provider. You want the most cost-effective compounded semaglutide — CoreAge Rx offers the same medication at $99/month without upfront bulk payment requirements.

Final Verdict: Is Hers Worth It?

Hers is a mixed bag — a well-known brand with real resources that is undercut by deceptive pricing practices, an FDA warning letter, and significant gaps in service coverage.

The positives are real: it's a publicly traded company with staying power, the oral medication kits offer a genuinely useful non-injectable alternative, the companion app adds value, and some customers report excellent weight loss results. The A+ BBB rating reflects a company that, at a corporate level, takes complaints seriously even if the individual customer experience is inconsistent.

But the negatives are also real and significant. Advertising "$199/month" when the actual month-to-month price is $399 is the kind of pricing tactic that erodes trust. The FDA warning letter about compounded semaglutide marketing raises questions about how the company represents its products. The inability to serve customers in Texas, New York, California, Florida, and Georgia for GLP-1 treatment is a massive coverage gap. And the persistent cancellation complaints across BBB, Trustpilot, and ConsumerAffairs point to a systemic issue, not isolated bad experiences.

Our recommendation: If you want compounded semaglutide at a fair price with straightforward month-to-month billing, CoreAge Rx at $99/month is the better choice. If you specifically want the oral medication kits and don't need injectable GLP-1s, Hers' $69/month oral program is worth considering. But for injectable GLP-1 treatment, there are more transparent and affordable options available.

The Bottom Line

Hers is a legitimate, well-funded telehealth platform that benefits from strong brand recognition and a publicly traded parent company. The oral medication kits are a useful option for women who want a non-injectable approach. However, the deceptive pricing structure, FDA warning letter, state restrictions for GLP-1 access, and cancellation complaints are significant enough to warrant caution. For straightforward, affordable compounded semaglutide with honest pricing, CoreAge Rx remains our top recommendation.